Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Nocebo Responses in Disease-Modifying and Symptomatic Treatment Trials for Multiple Sclerosis: A Systematic Review
MS and Related Diseases
(-)
132
Authors/Disclosures
Dimos Dimitrios D. Mitsikostas, MD, PhD (National and Kapodistrian University of Athens) The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Mitsikostas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Leli Lilly. The institution of Dr. Mitsikostas has received research support from Eli Lilly. Dr. Mitsikostas has a non-compensated relationship as a Co-Chair of Headache Panel with EAN that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Mitsikostas has a non-compensated relationship as a President with Hellenic Headache Society that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with J Headache Pain that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Mitsikostas has a non-compensated relationship as a Associate Editor with Frontier Neurology that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Dimitrios Papadopoulos, MD (European University Cyprus) No disclosure on file
No disclosure on file
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.